Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-25 07:19 am Unchanged |
2025-02-21 | 13D | Arbutus Biopharma Corporation ABUS |
Roivant Sciences Ltd. ROIV |
38,847,462 20.500% |
0 (Unchanged) |
Filing History |
| 2025-02-21 09:00 am Purchase |
2025-02-20 | 13D | Arbutus Biopharma Corporation ABUS |
Whitefort Capital Management, LP | 13,307,967 7.000% |
440,000 (+3.42%) |
Filing History |
| 2025-02-18 5:21 pm Unchanged |
2025-02-18 | 13D | Arbutus Biopharma Corporation ABUS |
Roivant Sciences Ltd. ROIV |
38,847,462 20.500% |
0 (Unchanged) |
Filing History |
| 2025-02-03 3:26 pm Purchase |
2024-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
MORGAN STANLEY MS |
21,524,661 11.400% |
2,132,173 (+10.99%) |
Filing History |
| 2024-11-14 08:41 am Sale |
2024-09-30 | 13G | Arbutus Biopharma Corporation ABUS |
Two Seas Capital LP | 8,387,388 4.400% |
-654,539 (-7.24%) |
Filing History |
| 2024-06-10 4:50 pm Purchase |
2024-05-31 | 13G | Arbutus Biopharma Corporation ABUS |
MORGAN STANLEY MS |
19,392,488 10.300% |
17,954,224 (+1248.33%) |
Filing History |
| 2024-05-17 09:03 am Unchanged |
2024-05-17 | 13D | Arbutus Biopharma Corporation ABUS |
Whitefort Capital Management, LP | 12,867,967 6.800% |
0 (Unchanged) |
Filing History |
| 2024-05-09 08:00 am Sale |
2024-05-02 | 13D | Arbutus Biopharma Corporation ABUS |
Whitefort Capital Management, LP | 12,867,967 6.800% |
-329,095 (-2.49%) |
Filing History |
| 2024-02-14 4:38 pm Purchase |
2023-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
Whitefort Capital Management, LP | 13,197,062 7.900% |
3,183,163 (+31.79%) |
Filing History |
| 2024-02-14 10:48 am Sale |
2023-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
Two Seas Capital LP | 9,041,927 5.400% |
-461,176 (-4.85%) |
Filing History |
| 2024-02-12 09:41 am Purchase |
2023-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
BLACKROCK INC BLK |
10,390,300 6.200% |
1,689,908 (+19.42%) |
Filing |
| 2023-11-21 08:00 am Purchase |
2023-11-21 | 13G | Arbutus Biopharma Corporation ABUS |
Two Seas Capital LP | 9,503,103 5.700% |
9,503,103 (New Position) |
Filing History |
| 2023-09-11 5:07 pm Purchase |
2023-09-01 | 13G | Arbutus Biopharma Corporation ABUS |
Whitefort Capital Management, LP | 10,013,899 6.000% |
10,013,899 (New Position) |
Filing History |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
BLACKROCK INC BLK |
8,700,392 5.600% |
8,700,392 (New Position) |
Filing |
| 2022-02-14 09:36 am Sale |
2021-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
RTW Investments, LP | 2,504,493 1.700% |
-3,473,862 (-58.11%) |
Filing History |
| 2021-10-20 5:13 pm Purchase |
2021-10-18 | 13D | Arbutus Biopharma Corporation ABUS |
Roivant Sciences Ltd. ROIV |
38,847,462 29.100% |
22,833,922 (+142.59%) |
Filing History |
| 2021-02-16 10:46 am Sale |
2020-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
Foresite Capital Fund IV, L.P. | 0 0.000% |
-3,705,128 (Position Closed) |
Filing History |
| 2021-02-12 09:23 am Purchase |
2020-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
RTW Investments, LP | 5,978,355 7.050% |
311,601 (+5.50%) |
Filing History |
| 2021-02-10 12:13 pm Sale |
2020-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
MORGAN STANLEY MS |
1,438,264 1.700% |
-2,059,314 (-58.88%) |
Filing History |
| 2020-07-16 4:22 pm Purchase |
2020-07-07 | 13G | Arbutus Biopharma Corporation ABUS |
MORGAN STANLEY MS |
3,497,578 5.100% |
3,497,578 (New Position) |
Filing History |